NEW YORK, June 12, 2017 /PRNewswire/ — WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of SciClone Pharmaceuticals Inc. (“SCLN” or the “Company”) (NASDAQ: SCLN) in connection with the proposed acquisition of…
June 13, 2017 at 03:10AM
from
No comments:
Post a Comment